Delivery Order SPE2DB22D2214-SPE2DB25FS2PN

Award Date 10/29/24
Potential Completion Date 10/30/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,989.08, is for the delivery of 4,566,034,371 units of procainamide 10ml 25s, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,425.06 for the procurement of Procainamide 1 gram/10 ml vials. The contract has a period of performance through May 21, 2025 and does not include a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $1,679.07, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that covers the procurement of Procainamide, a pharmaceutical product used for medical treatment. The contract has a firm fixed price pricing type and an ultimate completion date of December 17, 2024. Amerisourcebergen holds a larger...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,432.75 firm fixed-price delivery order is for the supply of 4565626834 - Procainamide 1 Gram/10 ML Vial 10ML, a critical pharmaceutical product. The contract has an ultimate completion date of August 30, 2024 and is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,491.24 firm fixed-price delivery order is for the supply of 4,564,528,683 units of the medication Procainamide 1,000 mg/10 ml vial. The contract has an ultimate completion date of May 8, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA through December...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the procurement of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,766.35, is for the delivery of Procainamide 1 gram/10 mL vials. The contract is a firm fixed-price delivery order with a completion date of February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,748.96 Firm Fixed Price Delivery Order contract is for the supply of Procainamide Hydrochloride, a pharmaceutical product, with a performance period through May 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,817.68 firm fixed-price delivery order is for the supply of PROCAINAMIDE 1 GRAM/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,850.12 fixed-price delivery order is for the supply of PROCAINAMIDE 1 GRAM/10 ML VIAL 10ML, a medical product. The contract has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS2PN
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,135.24, is for the delivery of 4,566,263,362 units of Procainamide 1,000 mg/2 ml vials. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 30, 2024.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award did not utilize any set-aside designations, indicating open competition.

Generated 5/20/25, 2:18 PM